Exploration of the Utility of Dental-dedicated MRI for Dentistry
Launched by DONALD NIXDORF · Apr 23, 2025
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new type of MRI specifically designed for dental issues. The goal is to see how this dental-focused MRI compares to traditional dental images, like X-rays and CT scans, that dentists usually use. The study focuses on various dental problems, including crowding, pain, and issues with the jaw joint. By understanding how well this new imaging technique works, researchers hope to improve the way dental conditions are diagnosed and treated.
If you are 18 years or older, need imaging for routine dental care, and have no serious health issues, you might be eligible to participate. Participants will need to attend a separate appointment for about two hours to have the dental MRI done. It's important to know that certain health conditions, pregnancy, and other factors may make you ineligible, so it's best to discuss with your healthcare provider if you have any questions. By taking part in this study, you can help advance dental care while also receiving additional imaging for your dental needs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient Age: 18 years old or older
- • 2. Receiving imaging for routine dental care
- • 3. Does not have a serious medical condition
- • 4. Is not pregnant or is not potentially pregnant
- • 5. Is willing and able to give consent in English
- • 6. Has the ability to manage their own calendar and schedule appointments
- • 7. Willing to have a separate 2-hour appointment to have an MRI
- Exclusion Criteria:
- • 1. Unable to consent to participant in English
- • 2. Serious health condition, which includes but not limited to renal failure/on dialysis, unstable heart disease (uncontrolled arrhythmia, cardiomyopathy and/or unable to lay flat, within 1 month of cardiac catheterization or myocardial infarction), unstable cerebral vascular disease (within 1 month of stroke and/or stent placement), diabetes (type I or II) not controlled by medication or diet, uncontrolled seizures, uncontrolled hyperthyroidism, non-allergic bronchospasm (chronic obstructive pulmonary disease and emphysema), uncontrolled movement disorder, and liver failure
- • 3. Pregnant and/or intending to become pregnant,
- • 4. Prisoner and/or not able to manage their own scheduling
- • 5. Screen positive on MR safety questionnaire, specifically including people that have worked with or otherwise been exposure to metal particles and have the potential for such particles to be embed within them.
About Donald Nixdorf
Donald Nixdorf is a distinguished clinical trial sponsor dedicated to advancing medical research through innovative studies and rigorous methodologies. With a focus on enhancing patient outcomes and contributing to the development of novel therapies, the organization collaborates with leading research institutions and healthcare professionals. By adhering to the highest ethical standards and regulatory requirements, Donald Nixdorf aims to ensure the integrity and reliability of its clinical trials, ultimately driving forward the advancement of healthcare solutions that benefit diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Trial Officials
Donald R Nixdorf, DDS, MS
Principal Investigator
University of Minneosta
Laurance Gaalaas, DDS, MS
Study Director
University of Minneosta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported